Glaxo says it will soon begin work on H1N1 vaccine

The pharmaceutical firm says it will finish producing season flu vaccine in July and could then turn to the swine flu. The World Health Organization is not expected to make a recommendation on producing a vaccine against the novel H1N1 influenza virus until next week, but GlaxoSmithKline said today it would begin work on a vaccine as soon as it receives a supply of the virus from the agency.

Read the whole article on LA Times - Science

More from LA Times - Science